Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Carcinoma × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Meningioma 3 Glioblastoma 3 Polycythemia Vera 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Gliosarcoma 2 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Nose Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Laryngeal Neoplasms 1 Hodgkin Disease 1 Glioma 1 Epstein-Barr Virus Infections 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Carboplatin 21 Cisplatin 14 pembrolizumab 12 Paclitaxel 12 Gemcitabine 12 Pemetrexed 9 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 6 durvalumab 5 Fluorouracil 5 Docetaxel 5 Cyclophosphamide 5 Axitinib 5 Albumin-Bound Paclitaxel 5 osimertinib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Ipilimumab 4 Erlotinib Hydrochloride 4 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 vosaroxin 2 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00468169 2019-10-09

EPIC

University of Chicago

Phase 2 Completed

110 enrolled 14 charts

Carcinoma, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡